Cite
HARVARD Citation
Khoja, L. et al. (n.d.). The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma. Cancer medicine. pp. 2792-2799. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Khoja, L. et al. (n.d.). The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma. Cancer medicine. pp. 2792-2799. [Online].